Signal active
Investment Firm
Overview
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud, marketplaces, frontier tech, biopharma, digital health, and medtech.
Highlights
1987
Venture Capital
11-50
793
265
167
Early Stage Venture, Late Stage Venture, Seed, Private Equity
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Canaan Partners, established in 1987 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Publishing, Content, Online Portals, Financial Services, Finance, FinTech, Personal Finance, Lending, Peer to Peer, Consumer Lending. The organization boasts a portfolio of 789 investments, with an average round size of $32.1M and 167 successful exits. Their recent investments include Associated Content, Lending Club, Norwest Venture Partners, Active Network, CRV. The highest investment round they participated in was $1821.8B. Among their most notable exits are Associated Content and Lending Club. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
793
170
265
167
Investments
793
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jul 10, 2024 | Nagish | Software | 11.0M |
Jul 16, 2024 | - | - | 150.0M |
Jul 24, 2024 | Autobahn Therapeutics | Biotechnology | 100.0M |
Aug 12, 2024 | Halda Therapeutics | Biotechnology | 126.0M |
Exits
167
Funding Timeline
793
0
18
Funding Rounds
793
Canaan Partners has raised 793 rounds. Their latest funding was raised on Aug 12, 2024 from a Series B - Halda Therapeutics round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jul 10, 2024 | Series A - Nagish | - | 11.0M | - |
Jul 16, 2024 | Series D - CatalYm | - | 150.0M | - |
Jul 24, 2024 | Series C - Autobahn Therapeutics | - | 100.0M | - |
Aug 12, 2024 | Series B - Halda Therapeutics | - | 126.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.